Insider acquisitions

Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.

Reset
Form 4, 4/A, 5 & 5/AAmounts retain the reported currency, when available.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page6
Other acquisitions44
Reporting owners21
Sales (not included)Not included in this datasetCheck original SEC filings

Oct 1, 2025 – Nov 3, 2025 · Transaction dates · Current page sample

Reported transaction sizes · security units

KINGSWAY Corp · Common Stock · Purchase (code P) · Non-derivative · Not reported

Reported transaction sizes by transaction date.Each point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.1770KINGSWAY Corp · Hansen Kent A (CFO & EVP) · Purchase · October 30, 2025 · Quantity 111 · Price 14.08 · Reference value 1,562.88 · Not reportedKINGSWAY Corp · Fitzgerald John Taylor Maloney (President and CEO · Director) · Purchase · October 30, 2025 · Quantity 177 · Price 14.08 · Reference value 2,492.16 · Not reportedOct 1, 2025Nov 3, 2025No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

50 dated transactions in this page sample · 21 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Oct 16, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.4945.37Not reported
Oct 15, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.3743.81Not reported
Oct 14, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.3543.55Not reported
Oct 13, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.5446.02Not reported
Oct 10, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.5946.67Not reported
Oct 9, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.5646.28Not reported
Oct 8, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.6347.19Not reported
Oct 7, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.1941.47Not reported
Oct 6, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.1440.82Not reported
Oct 3, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.2542.25Not reported
Oct 2, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.2842.64Not reported
Oct 1, 2025CUMBERLAND PHARMACEUTICALS INCCommon StockKAZIMI A J (Chairman and CEO · Director · 10% owner)Other acquisition133.3143.03Not reported
Oct 30, 2025KINGSWAY CorpCommon StockHansen Kent A (CFO & EVP)Purchase11114.081,562.88Not reported
Oct 30, 2025KINGSWAY CorpCommon StockFitzgerald John Taylor Maloney (President and CEO · Director)Purchase17714.082,492.16Not reported
Nov 1, 2025SouthState Bank CorpCommon StockSMITH G STACY (Director)Exercise / conversion1,13600Not reported
Oct 31, 2025IZEA Worldwide, Inc.Restricted Stock UnitsBIERE PETER (Chief Financial Officer)Stock award11,49500Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion6,94800Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion2,14500Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion1,77400Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion2,45500Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion2,28400Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion20000Not reported
Oct 31, 2025IZEA Worldwide, Inc.Common StockBIERE PETER (Chief Financial Officer)Exercise / conversion7900Not reported
Oct 31, 2025Ingredion IncPhantom StockSeip David Eric (SVP, Global Ops and CSCO)Stock award9.626115.411,110.93666Not reported
Oct 31, 2025Ingredion IncPhantom StockLeonard Michael J (SVP, CIO & Head of Prot. Fort.)Stock award28.597115.413,300.37977Not reported
Oct 30, 2025PETMED EXPRESS INCCommon StockLaCamp James (Director)Stock award34,86600Not reported
Oct 31, 2025AMETEK INC/Common StockOscher Ronald J (CHIEF ADMINISTRATIVE OFFICER)Exercise / conversion11,98085.451,023,691Not reported
Oct 31, 2025AMETEK INC/Common StockOscher Ronald J (CHIEF ADMINISTRATIVE OFFICER)Exercise / conversion14,31063.37906,824.7Not reported
Nov 3, 2025MSC INDUSTRIAL DIRECT CO INCClass A Common StockJACOBSON MITCHELL (Director · 10% owner)Purchase30,00084.792,543,700Not reported
Nov 3, 2025MSC INDUSTRIAL DIRECT CO INCClass A Common StockJACOBSON MITCHELL (Director · 10% owner)Purchase21,95483.92961,842,590.4384Not reported
Oct 31, 2025MSC INDUSTRIAL DIRECT CO INCClass A Common StockJACOBSON MITCHELL (Director · 10% owner)Purchase34,07384.76412,888,167.1793Not reported
Oct 30, 2025MSC INDUSTRIAL DIRECT CO INCClass A Common StockJACOBSON MITCHELL (Director · 10% owner)Purchase95,77984.92448,133,974.1076Not reported
Oct 30, 2025FLOTEK INDUSTRIES INC/CN/Common StockBlakeway Amy E. (SVP, GC and Secretary)Exercise / conversion6,000Not reportedNot reportedNot reported
Oct 30, 2025FLOTEK INDUSTRIES INC/CN/Common SharesCLEMENT JAMES BOND (Chief Financial Officer)Exercise / conversion15,000Not reportedNot reportedNot reported
Oct 30, 2025FLOTEK INDUSTRIES INC/CN/Common SharesEzell Ryan Gillis (CEO · Director)Exercise / conversion30,000Not reportedNot reportedNot reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)Bushman Julie L (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockBushman Julie L (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)KEEGAN JOSEPH D (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockKEEGAN JOSEPH D (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)HIGGINS JOHN L (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockHIGGINS JOHN L (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)Seth Alpna (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockSeth Alpna (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Option (Right to Buy)Herr Amy E. (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockHerr Amy E. (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Option (Right to Buy)Klimovsky Judith V. (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockKlimovsky Judith V. (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)Vessey Rupert (Director)Stock award3,77700Not reported
Oct 30, 2025BIO-TECHNE CorpCommon StockVessey Rupert (Director)Stock award1,64000Not reported
Oct 30, 2025BIO-TECHNE CorpStock Options (Right to Buy)BAUMGARTNER ROBERT V (Director)Stock award3,77700Not reported

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transaction details

Reporting owners, quantities, prices, and source filings.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.49Value: 45.37Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.37Value: 43.81Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.35Value: 43.55Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.54Value: 46.02Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.59Value: 46.67Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.56Value: 46.28Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.63Value: 47.19Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.19Value: 41.47Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.14Value: 40.82Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.25Value: 42.25Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.28Value: 42.64Not reportedView ↗
Transacted: CUMBERLAND PHARMACEUTICALS INCCPIX · company listings
KAZIMI A JChairman and CEO · Director · 10% owner
Other acquisitionCommon StockNon-derivative security · Code L133.31Value: 43.03Not reportedView ↗
Transacted: KINGSWAY CorpKWY · company listings
Hansen Kent ACFO & EVP
PurchaseCommon StockNon-derivative security · Code P11114.08Value: 1,562.88Not reportedView ↗
Transacted: KINGSWAY CorpKWY · company listings
Fitzgerald John Taylor MaloneyPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P17714.08Value: 2,492.16Not reportedView ↗
Transacted: SouthState Bank CorpSSB · company listingsExercise / conversionCommon StockNon-derivative security · Code M1,1360Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A11,4950Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M6,9480Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,1450Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,7740Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,4550Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2,2840Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M2000Value: 0Not reportedView ↗
Transacted: IZEA Worldwide, Inc.IZEA · company listings
BIERE PETERChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M790Value: 0Not reportedView ↗
Transacted: Ingredion IncINGR · company listings
Seip David EricSVP, Global Ops and CSCO
Stock awardPhantom StockDerivative security · Code A9.626115.41Value: 1,110.93666Not reportedView ↗
Transacted: Ingredion IncINGR · company listings
Leonard Michael JSVP, CIO & Head of Prot. Fort.
Stock awardPhantom StockDerivative security · Code A28.597115.41Value: 3,300.37977Not reportedView ↗
Transacted: PETMED EXPRESS INCPETS · company listings
LaCamp JamesDirector
Stock awardCommon StockNon-derivative security · Code A34,8660Value: 0Not reportedView ↗
Transacted: AMETEK INC/AME · company listings
Oscher Ronald JCHIEF ADMINISTRATIVE OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M11,98085.45Value: 1,023,691Not reportedView ↗
Transacted: AMETEK INC/AME · company listings
Oscher Ronald JCHIEF ADMINISTRATIVE OFFICER
Exercise / conversionCommon StockNon-derivative security · Code M14,31063.37Value: 906,824.7Not reportedView ↗
Transacted: MSC INDUSTRIAL DIRECT CO INCMSM · company listings
JACOBSON MITCHELLDirector · 10% owner
PurchaseClass A Common StockNon-derivative security · Code P30,00084.79Value: 2,543,700Not reportedView ↗
Transacted: MSC INDUSTRIAL DIRECT CO INCMSM · company listings
JACOBSON MITCHELLDirector · 10% owner
PurchaseClass A Common StockNon-derivative security · Code P21,95483.9296 *Value: 1,842,590.4384Not reportedView ↗
Transacted: MSC INDUSTRIAL DIRECT CO INCMSM · company listings
JACOBSON MITCHELLDirector · 10% owner
PurchaseClass A Common StockNon-derivative security · Code P34,07384.7641 *Value: 2,888,167.1793Not reportedView ↗
Transacted: MSC INDUSTRIAL DIRECT CO INCMSM · company listings
JACOBSON MITCHELLDirector · 10% owner
PurchaseClass A Common StockNon-derivative security · Code P95,77984.9244 *Value: 8,133,974.1076Not reportedView ↗
Transacted: FLOTEK INDUSTRIES INC/CN/FTK · company listings
Blakeway Amy E.SVP, GC and Secretary
Exercise / conversionCommon StockNon-derivative security · Code M6,000Not reported *Value: Not reportedNot reportedView ↗
Transacted: FLOTEK INDUSTRIES INC/CN/FTK · company listings
CLEMENT JAMES BONDChief Financial Officer
Exercise / conversionCommon SharesNon-derivative security · Code M15,000Not reported *Value: Not reportedNot reportedView ↗
Transacted: FLOTEK INDUSTRIES INC/CN/FTK · company listings
Ezell Ryan GillisCEO · Director
Exercise / conversionCommon SharesNon-derivative security · Code M30,000Not reported *Value: Not reportedNot reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listings
Seth AlpnaDirector
Stock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listings
Seth AlpnaDirector
Stock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listings
Herr Amy E.Director
Stock awardStock Option (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listings
Herr Amy E.Director
Stock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardCommon StockNon-derivative security · Code A1,6400Value: 0Not reportedView ↗
Transacted: BIO-TECHNE CorpTECH · company listingsStock awardStock Options (Right to Buy)Derivative security · Code A3,7770Value: 0Not reportedView ↗

Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →